Cannabis
Cannabis and the Aging Brain: New Research Challenges Old Assumptions
New February 2026 research shows moderate cannabis use may protect the brains of adults over 40. Users displayed larger hippocampus, amygdala, and striatum volumes, along with better memory, learning, and processing speed. Even past youth use showed benefits. While promising, effects vary by dose, brain region, and gender, so caution and further study are needed.
For years, the message has been the same: cannabis damages memory and weakens concentration. However, new research from February 2026 presents a very different perspective. For middle-aged and older adults, moderate exposure to cannabis may actually help protect the brain.
Researchers at the University of Colorado (CU Anschutz) analyzed data from thousands of individuals and reached unexpected conclusions. Adults over 40 who used cannabis often showed sharper cognitive abilities and healthier brain structures compared with people who had never used it.
Cannabis users showed greater volume in several key brain regions.
The team relied on extensive data from the UK Biobank, examining information from 26,362 participants. The average age was 55, with ages ranging from 40 to 77. Participants were divided into three categories: those who had never used cannabis, moderate users, and frequent users. Led by Dr. Anika Guha, the researchers focused on brain imaging and analyzed areas rich in CB1 cannabinoid receptors, where cannabis compounds have their strongest effects.
As people age, the brain naturally shrinks in a process known as atrophy, which is linked to memory decline and, in severe cases, dementia. The study identified a notable pattern: cannabis users showed greater volume in several key brain regions. These included the hippocampus, which is essential for memory, the amygdala, which regulates emotions, and the striatum, which influences movement and reward processes.
According to Dr. Guha, larger regional volume in the context of aging may signal preserved brain integrity. In simple terms, the brains of cannabis users appeared less affected by age-related changes.
The structural differences were reflected in cognitive performance. Participants who reported moderate cannabis use achieved better results in tests measuring short-term memory, processing speed, and learning ability. In some areas, such as visual memory, frequent users performed especially well, suggesting that the effects may depend on the level of exposure.
The findings also challenged earlier assumptions about youth exposure. It has long been believed that cannabis use during adolescence permanently harms the brain. However, UK Biobank data showed that individuals who used cannabis only when they were younger and stopped later still displayed greater brain volume in CB1-rich areas and stronger cognitive performance than those who had never used it.
Researchers suspect that cannabis may have anti-inflammatory properties and that activation of the endocannabinoid system could help protect against neurodegenerative processes.
Despite the encouraging results, scientists stress caution. Cannabis is not a universal solution. The study identified smaller volume in the posterior cingulate cortex among users, an area linked to memory and emotion. Researchers also lacked detailed information about the types of cannabis used, including THC or CBD content, and noted differences in how men and women responded, indicating the need for further study.
Overall, the February 2026 findings suggest that cannabis affects the aging brain in complex ways. Moderate use may help preserve brain structure, but careful interpretation remains essential as research continues.
__
(Featured image by Ahmed Zayan via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Fintech7 days agoNubank Launches in Argentina With $474M Bet to Shake Up the Fintech Market
-
Cannabis2 weeks agoColombia’s Medical Cannabis Industry Sees Rapid Growth and Expanding Adoption
-
Biotech4 days agoWhy Bioceres Shares Slide Into Penny Stock Territory
-
Biotech2 weeks agoCIPM Expands Drug Funding and Indications



